SJ , - I too like Mr Chen questions , but looks to
Post# of 148170
Our BLA is delayed for one month , and from this ridiculous price of 1.50 , he goes to more ridiculous of 1.00 , over 33% down ???
I am sorry SJ , knowing how many drug resistant HIV patients are in USA and globally , thinking that we have most probably best PrEP drug globally , and all of this will happen within one year , and giving this company
600 - 700 Mill value is not a good analysis IMO.
I am not talking even mono in HIV or cancers or GvHD , MS and any other disease.
Sorry , but in no way I can agree with this analysis !!!!!
I think I will apply for a job of analyst or adviser in some biotech...maybe Gilead , I see they need help very badly now .
All IMO of course.